Health systems analysis and evaluation of the barriers to availability, utilisation and readiness of sexual and reproductive health services in COVID-19-affected areas: a WHO mixed-methods study protocol.
COVID-19
public health
reproductive medicine
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
entrez:
1
6
2022
pubmed:
2
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
COVID-19 has led to an unprecedented increase in demand on health systems to care for people infected, necessitating the allocation of significant resources, especially medical resources, towards the response. This, compounded by the restrictions on movement instituted may have led to disruptions in the provision of essential services, including sexual and reproductive health (SRH) services. This study aims to assess the availability of contraception, comprehensive abortion care, sexually transmitted infection prevention and treatment and sexual and gender-based violence care and support services in local health facilities during COVID-19 pandemic. This is a standardised generic protocol designed for use across different global settings. This study adopts both quantitative and qualitative methods to assess health facilities' SRH service availability and readiness, and clients' and providers' perceptions of the availability and readiness of these services in COVID-19-affected areas. The study has two levels: (1) perceptions of clients (and the partners) and healthcare providers, using qualitative methods, and (2) assessment of infrastructure availability and readiness to provide SRH services through reviews, facility service statistics for clients and a qualitative survey for healthcare provider perspectives. The health system assessment will use a cross-sectional panel survey design with two data collection points to capture changes in SRH services availability as a result of the COVID-19 epidemic. Data will be collected using focus group discussions, in-depth interviews and a health facility assessment survey. Ethical approval for this study was obtained from the WHO Scientific and Ethics Review Committee (protocol ID CERC.0103). Each study site is required to obtain the necessary ethical and regulatory approvals that are required in each specific country.
Identifiants
pubmed: 35649598
pii: bmjopen-2021-057810
doi: 10.1136/bmjopen-2021-057810
pmc: PMC9160592
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e057810Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Investigateurs
Luis Bahamondes
(L)
Jose Guilherme Cecatti
(JG)
Eunice Chomi
(E)
Seni Kouanda
(S)
Kun Tang
(K)
Hanxiyue Zhang
(H)
Yifan Zhu
(Y)
Yueping Guo
(Y)
Ge Yang
(G)
Chunxiao Peng
(C)
Deda Ogum Alangea
(DO)
Kwasi Tropsey
(K)
Emefa Judith Modey
(EJ)
Rozina Karmaliani
(R)
Laila Ladak
(L)
Pisake Lumbiganon
(P)
Jen Sothornwit
(J)
Marleen Temmerman
(M)
Abdu Mohiddin
(A)
Ferdinand Okwaro
(F)
Massimo Mirandola
(M)
Maddalena Cordioli
(M)
Alessia Savoldi
(A)
Simone Garzon
(S)
Stefano Uccella
(S)
Ranieri Poli
(R)
Nigel Sherriff
(N)
Alexandra Sawyer
(A)
Jorg Huber
(J)
Jaime Vera
(J)
Debbie Williams
(D)
Moazzam Ali
(M)
Caron Kim
(C)
Hamsadvani Kuganantham
(H)
Igor Toskin
(I)
Vanessa Brizuela
(V)
Anna Thorson
(A)
Joy Jerop Chebet
(JJ)
Hugo Gamerro Abrego
(HG)
Soe Soe Thwin
(SS)
Armando Seuc
(A)
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Adv Nurs. 2008 Apr;62(1):107-15
pubmed: 18352969
Sex Reprod Health Matters. 2020 Dec;28(1):1746065
pubmed: 32191167
Glob Bioeth. 2018 Oct 3;31(1):104-119
pubmed: 33343186
Health Policy Plan. 2021 Apr 21;36(3):360-368
pubmed: 33881138
Am J Bioeth. 2017 Mar;17(3):3-14
pubmed: 28207365
Int Perspect Sex Reprod Health. 2020 Apr 16;46:73-76
pubmed: 32343244